4/20/2010

A report from Express Scripts shows that drug firms increased prices on brand-name drugs 9.1% in 2009. The growth in prices was "exacerbated by the health-care reform debate," said Steve Miller, senior vice president and chief medical officer of Express Scripts.

Related Summaries